Literature DB >> 27003300

Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of Industrialization.

Shennin N Yuen1, Holly Kramer1, Amy Luke1, Pascal Bovet1, Jacob Plange-Rhule1, Terrence Forrester1, Vicki Lambert1, Myles Wolf1, Pauline Camacho1, Regina Harders1, Lara Dugas1, Richard Cooper1, Ramon Durazo-Arvizu1.   

Abstract

CONTEXT: Compensatory increases in fibroblast growth factor 23 (FGF23) with increasing phosphate intake may adversely impact health. However, population and clinical studies examining the link between phosphate intake and FGF23 levels have focused mainly on populations living in highly industrialized societies in which phosphate exposure may be homogenous.
OBJECTIVE: The objective of the study was to contrast dietary phosphate intake, urinary measures of phosphate excretion, and FGF23 levels across populations that differ by the level of industrialization.
DESIGN: This was a cross-sectional analysis of three populations.
SETTING: The study was conducted in Maywood, Illinois; Mahé Island, Seychelles; and Kumasi, Ghana. PARTICIPANTS: Adults with African ancestry aged 25-45 years participated in the study. MAIN OUTCOME: FGF23 levels were measured.
RESULTS: The mean age was 35.1 (6.3) years and 47.9% were male. Mean phosphate intake and fractional excretion of phosphate were significantly higher in the United States vs Ghana, whereas no significant difference in phosphate intake or fractional excretion of phosphate was noted between the United States and Seychelles for men or women. Overall, median FGF23 values were 57.41 RU/mL (interquartile range [IQR] 43.42, 75.09) in the United States, 42.49 RU/mL (IQR 33.06, 55.39) in Seychelles, and 33.32 RU/mL (IQR 24.83, 47.36) in Ghana. In the pooled sample, FGF23 levels were significantly and positively correlated with dietary phosphate intake (r = 0.11; P < .001) and the fractional excretion of phosphate (r = 0.13; P < .001) but not with plasma phosphate levels (r = -0.001; P = .8). Dietary phosphate intake was significantly and positively associated with the fractional excretion of phosphate (r = 0.23; P < .001).
CONCLUSION: The distribution of FGF23 levels in a given population may be influenced by the level of industrialization, likely due to differences in access to foods preserved with phosphate additives.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27003300      PMCID: PMC4870853          DOI: 10.1210/jc.2015-3558

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Hidden sources of phosphorus in the typical American diet: does it matter in nephrology?

Authors:  Jaime Uribarri; Mona S Calvo
Journal:  Semin Dial       Date:  2003 May-Jun       Impact factor: 3.455

2.  DIURNAL VARIATION IN URINARY EXCRETION OF CALCIUM AND PHOSPHATE AND ITS RELATION TO BLOOD LEVELS.

Authors:  B M CARRUTHERS; D H COPP; H W MCINTOSH
Journal:  J Lab Clin Med       Date:  1964-06

3.  FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.

Authors:  Takashi Shimada; Hisashi Hasegawa; Yuji Yamazaki; Takanori Muto; Rieko Hino; Yasuhiro Takeuchi; Toshiro Fujita; Kazuhiko Nakahara; Seiji Fukumoto; Takeyoshi Yamashita
Journal:  J Bone Miner Res       Date:  2003-12-29       Impact factor: 6.741

4.  Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

Authors:  Serge L Ferrari; Jean-Philippe Bonjour; René Rizzoli
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

5.  Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

Authors:  Diana M Antoniucci; Takeyoshi Yamashita; Anthony A Portale
Journal:  J Clin Endocrinol Metab       Date:  2006-05-30       Impact factor: 5.958

6.  Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production.

Authors:  Hitoshi Saito; Kenichiro Kusano; Masahiko Kinosaki; Hirotaka Ito; Michinori Hirata; Hiroko Segawa; Ken-Ichi Miyamoto; Naoshi Fukushima
Journal:  J Biol Chem       Date:  2002-11-04       Impact factor: 5.157

7.  Close correlation between estrogen treatment and renal phosphate reabsorption capacity.

Authors:  H Uemura; M Irahara; N Yoneda; T Yasui; K Genjida; K I Miyamoto; T Aono; E Takeda
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

8.  Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women.

Authors:  Sherri -Ann M Burnett; Samantha C Gunawardene; F Richard Bringhurst; Harald Jüppner; Hang Lee; Joel S Finkelstein
Journal:  J Bone Miner Res       Date:  2006-08       Impact factor: 6.741

9.  Circulating Fibroblast Growth Factor 23 Has a U-Shaped Association With Atrial Fibrillation Prevalence.

Authors:  Masatoshi Miyamura; Shu-ichi Fujita; Hideaki Morita; Kazushi Sakane; Yusuke Okamoto; Koichi Sohmiya; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  Circ J       Date:  2015-05-27       Impact factor: 2.993

10.  Physiological responses of human adults to foods containing phosphate additives.

Authors:  R R Bell; H H Draper; D Y Tzeng; H K Shin; G R Schmidt
Journal:  J Nutr       Date:  1977-01       Impact factor: 4.798

View more
  9 in total

Review 1.  Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.

Authors:  Giovanni Lombardi; Mosè Barbaro; Massimo Locatelli; Giuseppe Banfi
Journal:  Endocrine       Date:  2017-02-08       Impact factor: 3.633

2.  A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.

Authors:  Naohiko Fujii; Takayuki Hamano; Jesse Y Hsu; Enyu Imai; Tadao Akizawa; Kosaku Nitta; Tsuyoshi Watanabe; Satoshi Iimuro; Yasuo Ohashi; Seiichi Matsuo; Hirofumi Makino; Akira Hishida; Arnold B Alper; Edward J Horwitz; Chi-Yuan Hsu; Anna C Porter; Myles Wolf; Wei Yang; Lisa Nessel; Harold I Feldman
Journal:  Am J Nephrol       Date:  2022-02-28       Impact factor: 4.605

3.  Fibroblast Growth Factor-23 and a Vegetarian Diet.

Authors:  Shuchi Anand; Ram Jagannathan; Ruby Gupta; Sailesh Mohan; Dorairaj Prabhakaran; Myles Wolf
Journal:  J Ren Nutr       Date:  2020-04-01       Impact factor: 3.655

4.  Incidence rate of vitamin D deficiency and FGF23 levels in 12- to 13-year-old adolescents in Japan.

Authors:  Satomi Koyama; Takuo Kubota; Junko Naganuma; Osamu Arisaka; Keiichi Ozono; Shigemi Yoshihara
Journal:  J Bone Miner Metab       Date:  2020-11-18       Impact factor: 2.626

5.  Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.

Authors:  Dominique Kosk; Holly Kramer; Amy Luke; Pauline Camacho; Pascal Bovet; Jacob Plange Rhule; Terrence Forrester; Myles Wolf; Chris Sempos; Michal L Melamed; Lara R Dugas; Richard Cooper; Ramon Durazo-Arvizu
Journal:  J Bone Miner Metab       Date:  2016-12-09       Impact factor: 2.626

6.  Fibroblast Growth Factor 23 is Associated with a Frequent Exacerbator Phenotype in COPD: A Cross-Sectional Pilot Study.

Authors:  Swati Gulati; J Michael Wells; Gisel P Urdaneta; Kira Balestrini; Isabel Vital; Katherine Tovar; Jarrod W Barnes; Surya P Bhatt; Michael Campos; Stefanie Krick
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

7.  High Fibroblast Growth Factor 23 as a Biomarker for Severe Cardiac Impairment in Children with Chronic Kidney Disease: A Single Tertiary Center Study.

Authors:  Retno Palupi-Baroto; Kristia Hermawan; Indah Kartika Murni; Tiara Nurlitasari; Yuli Prihastuti; Debora Roselita Karo Sekali; Cahyani Gita Ambarsari
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-06-08

8.  Effects of vitamin D supplementation on FGF23: a randomized-controlled trial.

Authors:  Christian Trummer; Verena Schwetz; Marlene Pandis; Martin R Grübler; Nicolas Verheyen; Martin Gaksch; Armin Zittermann; Winfried März; Felix Aberer; Julia Steinkellner; Claudia Friedl; Vincent Brandenburg; Jakob Voelkl; Ioana Alesutan; Barbara Obermayer-Pietsch; Thomas R Pieber; Andreas Tomaschitz; Stefan Pilz
Journal:  Eur J Nutr       Date:  2018-03-30       Impact factor: 5.614

Review 9.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.